Pure Global AI
NCT06146361Recruiting

Vale+Tú Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19

Vale+ Tu Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19.
The University of Texas Health Science Center, HoustonClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
COVID-19
Drug/Device/Intervention
COVID-19 Group Problem Solving
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
The University of Texas Health Science Center, Houston
Location
Houston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Nov 03, 2023
End date
Jan 19, 2024
Enrollment
360 participants
Primary outcome

Change in COVID-19 Vaccination Status assessed by a survey,Change in Mask Wearing frequency as assessed by a survey,Percentage of participants who reported contacting the gold card agency,Percentage of participants who reported contacting the agency for assistance to get food,Percentage of participants who reported contacting the agency for assistance with health care resources

Summary

The purpose of this study is to assess the extent to which LDL report increased adherence
 with COVID 19 mitigation practices 1 month post intervention.

ICD-10 classifications
COVID-19, virus identifiedCOVID-19, virus not identifiedCoronavirus infection, unspecified siteViral infection, unspecifiedRift Valley fever
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06146361
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06146361 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Texas Health Science Center, Houston and is currently Recruiting. The study focuses on COVID-19. Target enrollment is 360 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.